DL-Methyldopa

• Description :

  DL-Methyldopa (rac α-Methyl DOPA) (Compound 14) is a centrally acting α2-adrenergic receptor agonist. DL-Methyldopa can serve as an intermediate in neurotransmitter biosynthesis. DL-Methyldopa can be used in research on neurological diseases[1].

• Product Name Alternative :

  Rac α-Methyl DOPA

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H312-H332

• Target :

  Adrenergic Receptor

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Field of Research :

  Neurological Disease

• Smiles :

  O=C(C(C)(CC1=CC=C(C(O)=C1)O)N)O

• Molecular Formula :

  C10H13NO4

• Molecular Weight :

  211.21

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501

• References & Citations :

  [1]Kang-Yell Choi, et al. Compositions and methods for suppressing and/or treating neurodegenerative diseases and/or a clinical condition thereof.WO2021090172 A1. 2022-05-04.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [55-40-3]